The role of nanobiotechnology in drug discovery

被引:127
作者
Jain, KK [1 ]
机构
[1] Jain PharmaBiotech, CH-4057 Basel, Switzerland
关键词
D O I
10.1016/S1359-6446(05)03573-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The application of nanotechnology in life sciences, nanobiotechnology, is already having an impact on diagnostics and drug delivery. Now, researchers are starting to use nanotechnology in the field of drug discovery. This review explains how several technologies, including nanoparticles and nanodevices such as nanobiosensors and nanobiochips, are used to improve drug discovery and development. Nanoscale assays can contribute significantly to cost-saving in screening campaigns. In addition, some nanosubstances (such as fullerenes) could be potential drugs for the future. Although there might be some safety concerns with respect to the in vivo use of nanoparticles, studies are in place to determine the nature and extent of adverse events. Future prospects for the application of nanotechnology in healthcare and for the development of personalized medicine appear to be excellent.
引用
收藏
页码:1435 / 1442
页数:8
相关论文
共 30 条
[21]   Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles [J].
Kirkham, M ;
Fujita, A ;
Chadda, R ;
Nixon, SJ ;
Kurzchalia, TV ;
Sharma, DK ;
Pagano, RE ;
Hancock, JF ;
Mayor, S ;
Parton, RG .
JOURNAL OF CELL BIOLOGY, 2005, 168 (03) :465-476
[22]   Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer [J].
Kukowska-Latallo, JF ;
Candido, KA ;
Cao, ZY ;
Nigavekar, SS ;
Majoros, IJ ;
Thomas, TP ;
Balogh, LP ;
Khan, MK ;
Baker, JR .
CANCER RESEARCH, 2005, 65 (12) :5317-5324
[23]   Effect of different anti-Aβ antibodies on Aβ fibrillogenesis as assessed by atomic force microscopy [J].
Legleiter, J ;
Czilli, DL ;
Gitter, B ;
DeMattos, RB ;
Holtzman, DM ;
Kowalewski, T .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 335 (04) :997-1006
[24]   Coupling between clathrin-coated-pit invagination, cortactin recruitment, and membrane scission observed in live cells [J].
Merrifield, CJ ;
Perrais, D ;
Zenisek, D .
CELL, 2005, 121 (04) :593-606
[25]   Quantum dots and other nanoparticles: what can they offer to drug discovery? [J].
Ozkan, M .
DRUG DISCOVERY TODAY, 2004, 9 (24) :1065-1071
[26]   Nanobodies as novel agents for cancer therapy [J].
Revets, H ;
De Baetselier, P ;
Muyldermans, S .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (01) :111-124
[27]   Improvement in peptide detection for proteomics analyses using nanoLC-MS and high-field asymmetry waveform ion mobility mass spectrometry [J].
Venne, K ;
Bonneil, E ;
Eng, K ;
Thibault, P .
ANALYTICAL CHEMISTRY, 2005, 77 (07) :2176-2186
[28]   Label-free detection of small-molecule-protein interactions by using nanowire nanosensors [J].
Wang, WU ;
Chen, C ;
Lin, KH ;
Fang, Y ;
Lieber, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (09) :3208-3212
[29]   Mesoporous membrane device for asymmetric biosensing [J].
Wang, ZG ;
Haasch, RT ;
Lee, GU .
LANGMUIR, 2005, 21 (04) :1153-1157
[30]   Nanomedicine: Fullerene and carbon nanotube biology [J].
Wilson, SR .
PERSPECTIVES OF FULLERENE NANOTECHNOLOGY, 2002, :155-163